65,437 trials
Food Protein-Induced Enterocolitis Syndrome · Allergies · Pediatric Disorder
Primary: Negative Predictive Value (NPV), Defined as the Percentage of Test-predicted Safe Foods That Are Actually Safe Foods. — 98.5; 73.16 percentage — p=<0.0001
Diabetic Macular Edema (DME)
Primary: Systemic Safety and Tolerability of a Single IVT Injection of UBX1325. — 4; 5; 9; 0 Participants
Solid Tumor · Lymphoma · Osteosarcoma
Primary: Number of Patients With Dose-Limiting Toxicities (DLT) — 0; 2 Participants
Short Bowel Syndrome
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 3 Participants
Osseointegrated Dental Implantation · Pain, Acute
Primary: Pain Intensity Scores on Numeric Pain Intensity Scale 0-6 Hours — 1; 3 score on a scale — p=<0.05
Lung Tuberculosis · MDR TB
Primary: Number of MDR TB Cases Amongst New TB Cases and Previously Treated TB Cases — 23; 64 Participants
Metastatic Urothelial Cancer
Primary: Objective Response Rate (ORR) — 69.6; 33.3 Percentage of participants
Ankle Osteoarthritis
Primary: FAOS - PAIN — 20.8 score on a scale
Reading Problem
Primary: Change in Knowledge Accessibility and Availability — 13.2; 13.7; 12.28; 13.50 score on a scale (0 to 14)
Yellow Fever
Primary: Occurrence of All Serious Adverse Events (SAEs) at Any Time During the Study — 0; 0; 0 Serious Adverse Event
Parkinson's Disease
Primary: 31P-MRS Redox Ratio — 0.3856 Change in 31P-MRS Redox Ratio — p=0.1077
BK Virus Nephropathy · BK Virus Infection
Primary: Number of Participants Who Experienced a Treatment-emergent Adverse Event (TEAE) — 17; 17; 16 Participants
Food Allergy
Primary: 600mg Desensitization in at Least One Qualifying Food — 8; 11; 4 Participants
Anxiety and Fear
Primary: Fear and Avoidance of Memory Loss (FAM) Scale Score at Follow-up — 63.9; 60.3 score on a scale
Penicillin Allergy · Pediatric Emergency Medicine
Primary: Number of Oral Amoxicillin Challenge Participants Completing Challenge With Insignificant Adverse Result — 114; 2 Participants